The results of a recent study moved University of Arizona Health Sciences researchers one step closer to developing effective vaccinations against flaviviruses, which infect more than 400 million people...

By NewsDesk  @bactiman63 With flu season approaching, the American Medical Association (AMA) is urging everyone six months and older to get vaccinated against the flu. During the 2020-2021 flu season,...

Sanofi Pasteur India announced the launch of Tetraxim® (DTaP-IPV). The booster vaccine is indicated for preschoolers and provides protection against four major diseases – Diphtheria, Pertussis,...

Clover Biopharmaceuticals, a global clinical-stage biotechnology company focused on discovering and developing transformative biologic therapies and vaccines, today announced positive preclinical data...

Eveliqure Biotechnologies GmbH, an Austrian biotechnology company, today announces the initiation of clinical testing for its ShigETEC vaccine candidate, with the dosing of the first subject in a Phase...

By NewsDesk  @infectiousdiseasenews According to the Swedish Public Health Agency’s and the Medical Products Agency’s joint annual report for 2019, adherence to the vaccination program remains...

A new study conducted by IVI in collaboration with SK bioscience shows that single-dose and two-dose regimens of Vi-DT typhoid conjugate vaccine (TCV) are safe and immunogenic in children 6-23 months of...

Almost seven in 10 Americans would be interested in receiving a COVID-19 vaccine when one becomes available, according to a new study. But researchers say there are concerning gaps in interest, particularly...

Valneva SE, a specialty vaccine company focused on prevention of diseases with major unmet needs, today announced the initiation of a pivotal Phase 3 clinical trial for its differentiated, single-shot...

Results from two early-phase Russian non-randomised vaccine trials (Sputnik V) in a total of 76 people are published this week in The Lancet, finding that two formulations of a two-part vaccine have a...